HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam F Sander Selected Research

Vaccines

5/2022Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis.
12/2021Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
1/2021Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
7/2020A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice.
1/2019A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine.
1/2019Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum.
1/2018Virus-like particle display of HER2 induces potent anti-cancer responses.
1/2017Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
11/2016Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
4/2016Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam F Sander Research Topics

Disease

11Malaria
03/2020 - 06/2008
4Neoplasms (Cancer)
01/2019 - 10/2015
2Hypersensitivity (Allergy)
05/2022 - 04/2016
2COVID-19
12/2021 - 10/2021
2Infections
01/2021 - 06/2011
2Noncommunicable Diseases
01/2018 - 04/2016
1Skin Diseases (Skin Disease)
05/2022
1Allergic Contact Dermatitis
05/2022
1Human Influenza (Influenza)
07/2020
1Papillomavirus Infections
01/2019
1Glioma (Gliomas)
01/2019
1Carcinoma (Carcinomatosis)
01/2018
1Parasitic Diseases (Parasitic Disease)
11/2016
1Neoplasm Metastasis (Metastasis)
10/2015

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
05/2022 - 01/2015
8Proteins (Proteins, Gene)FDA Link
07/2020 - 06/2011
5AntigensIBA
07/2020 - 06/2011
4Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2019 - 06/2008
3Immunoglobulin G (IgG)IBA
07/2020 - 11/2016
3AntibodiesIBA
01/2019 - 06/2008
2Proteoglycans (Proteoglycan)IBA
01/2019 - 10/2015
1AllergensIBA
05/2022
1NanovaccinesIBA
10/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
07/2020
1EpitopesIBA
07/2020
1Hemagglutinins (Hemagglutinin)IBA
07/2020
1Endothelial Protein C ReceptorIBA
03/2020
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Epidermal Growth Factor (EGF)IBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1Malaria VaccinesIBA
11/2016
1AutoantigensIBA
04/2016
1GlycosaminoglycansIBA
10/2015
1Diphtheria ToxinIBA
10/2015
1hemiasterlinIBA
10/2015
1Plasmodium falciparum erythrocyte membrane protein 1IBA
02/2014

Therapy/Procedure

1Therapeutics
01/2018